Bowei Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Atherosclerosis and Cardiovascular Diseases
- Phagocytosis and Immune Regulation
Papers in
-
- Sirtuins and Resveratrol in Medicine 2
- Co-authors
- Yuanpeng Xia (5 shared papers)Bo Hu (2 shared papers)Ling Mao (4 shared papers)Xueying Luo (4 shared papers)Shengcai Chen (3 shared papers)Zi‐Ming Ye (2 shared papers)Huijuan Jin (2 shared papers)Yanan Li (2 shared papers)
In The Last Decade
Bowei Li
23 papers receiving 636 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 130
- Immunology 184
- Biological Psychiatry 10
- Neurology 30
- Molecular Biology 231
Countries citing papers authored by Bowei Li
This map shows the geographic impact of Bowei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bowei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bowei Li more than expected).
Fields of papers citing papers by Bowei Li
This network shows the impact of papers produced by Bowei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bowei Li. The network helps show where Bowei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Bowei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 167 | |
| 2 | 2020 | 109 | |
| 3 | 2019 | 69 | |
| 4 | 2023 | 67 | |
| 5 | 2017 | 42 | |
| 6 | 2018 | 36 | |
| 7 | 2024 | 20 | |
| 8 | 2021 | 19 | |
| 9 | 2017 | 18 | |
| 10 | 2023 | 13 | |
| 11 | 2018 | 11 | |
| 12 | 2020 | 10 | |
| 13 | Hypertensive vascular remodeling was inhibited by Xuezhikang through the regulation of Fibulin-3 and MMPs in spontaneously hypertensive rats. | 2015 | 10 |
| 14 | 2022 | 9 | |
| 15 | 2020 | 8 | |
| 16 | 2025 | 6 | |
| 17 | 2025 | 6 | |
| 18 | 2022 | 4 | |
| 19 | 2016 | 4 | |
| 20 | 2025 | 4 |
About Bowei Li
Bowei Li is a scholar working on Immunology, Geriatrics and Gerontology, Neurology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 28 papers that have together received 641 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Diabetes Treatment and Management (3 papers), Alzheimer's disease research and treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Water Treatment and Disinfection (2 papers), Computational Drug Discovery Methods (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Cancer Research (130 citations), Immunology (184 citations), Biological Psychiatry (10 citations), Neurology (30 citations) and Molecular Biology (231 citations). Bowei Li has collaborated with scholars based in China, Hong Kong and Macao. Frequent co-authors include Yuanpeng Xia, Bo Hu, Ling Mao, Xueying Luo, Shengcai Chen, Zi‐Ming Ye, Huijuan Jin, Yanan Li, Chao Qin and Shuai Yang. Their work appears in journals such as Advanced Science, Cellular and Molecular Life Sciences, Theranostics, Journal of Gastroenterology and Hepatology and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.